{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T21:04:51Z","timestamp":1789506291985,"version":"build-2803163510"},"reference-count":95,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2011,5,9]],"date-time":"2011-05-09T00:00:00Z","timestamp":1304899200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Surgical Oncology"],"published-print":{"date-parts":[[2011,9,15]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Molecular signatures of melanoma have propelled new approaches to early diagnosis, monitoring of treatment response, and targeted therapy. This review discusses messenger RNA (mRNA), genomic, and epigenomic melanoma biomarkers in blood and tissue specimens. The major focus is on tissue\u2010based molecular assays to upstage sentinel lymph nodes (SLNs), and blood\u2010based assays to detect melanoma progression by monitoring levels of circulating tumor cells (CTC) and circulating DNA. J. Surg. Oncol. 2011; 104:438\u2013446. \u00a9 2011 Wiley\u2010Liss, Inc.<\/jats:p>","DOI":"10.1002\/jso.21969","type":"journal-article","created":{"date-parts":[[2011,5,10]],"date-time":"2011-05-10T10:49:45Z","timestamp":1305024585000},"page":"438-446","source":"Crossref","is-referenced-by-count":19,"title":["Prognostic molecular biomarkers for cutaneous malignant melanoma"],"prefix":"10.1002","volume":"104","author":[{"given":"Ryo","family":"Tanaka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Koyanagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiko","family":"Narita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave S.B.","family":"Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2011,5,9]]},"reference":[{"key":"e_1_2_6_2_2","first-page":"441","article-title":"Expression of differentiation melanoma\u2010associated antigen genes is associated with favorable disease outcome in advanced\u2010stage melanomas","volume":"63","author":"Takeuchi H","year":"2003","journal-title":"Cancer Res"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.9.3515"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1997.15.8.2818"},{"key":"e_1_2_6_5_2","doi-asserted-by":"crossref","first-page":"2826","DOI":"10.1200\/JCO.1997.15.8.2826","article-title":"Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients","volume":"15","author":"Jung FA","year":"1997","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2004.045096"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-4198"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-10-0037"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.0958"},{"key":"e_1_2_6_10_2","first-page":"411","article-title":"Assessment of messenger RNA of beta 1\u2002\u2192\u20024\u2010N\u2010acetylgalactosaminyl\u2010transferase as a molecular marker for metastatic melanoma","volume":"4","author":"Kuo CT","year":"1998","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2004.12.009"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1245\/ASO.2004.11.910"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1007\/0-387-23604-X_12"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1084\/jem.179.3.921"},{"key":"e_1_2_6_15_2","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/clinchem\/47.3.505","article-title":"Molecular strategy for detecting metastatic cancers with use of multiple tumor\u2010specific MAGE\u2010A genes","volume":"47","author":"Miyashiro I","year":"2001","journal-title":"Clin Chem"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/78.1.55"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/78.1.45"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/1096-8628(200024)97:4<280::AID-AJMG1278>3.0.CO;2-N"},{"key":"e_1_2_6_19_2","first-page":"823","article-title":"PAX3 is expressed in human melanomas and contributes to tumor cell survival","volume":"61","author":"Scholl FA","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-05-1847"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.1615\/CritRevImmunol.v24.i4.40"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2009.00660.x"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.1101\/gad.1302105"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1523\/JNEUROSCI.2512-05.2005"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.plipres.2004.05.001"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2505"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.1038\/jid.2009.195"},{"key":"e_1_2_6_28_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.21267"},{"key":"e_1_2_6_29_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(00)80165-X"},{"key":"e_1_2_6_30_2","doi-asserted-by":"publisher","DOI":"10.1002\/ijc.22024"},{"key":"e_1_2_6_31_2","doi-asserted-by":"publisher","DOI":"10.1136\/jcp.2005.032144"},{"key":"e_1_2_6_32_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.semcancer.2008.10.012"},{"key":"e_1_2_6_33_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2007.05.013"},{"key":"e_1_2_6_34_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1755-148X.2009.00554.x"},{"key":"e_1_2_6_35_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-69219-7_13"},{"key":"e_1_2_6_36_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-006-8500-x"},{"key":"e_1_2_6_37_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1887"},{"key":"e_1_2_6_38_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-03-0195"},{"key":"e_1_2_6_39_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000217690.65909.9c"},{"key":"e_1_2_6_40_2","doi-asserted-by":"publisher","DOI":"10.1038\/nature01726"},{"key":"e_1_2_6_41_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-07-2025"},{"key":"e_1_2_6_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2009.12.003"},{"key":"e_1_2_6_43_2","doi-asserted-by":"publisher","DOI":"10.3322\/canjclin.56.5.292"},{"key":"e_1_2_6_44_2","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-38327-9_20"},{"key":"e_1_2_6_45_2","first-page":"883","volume-title":"Cutaneous melanoma","author":"Grimm EA","year":"2008"},{"key":"e_1_2_6_46_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181724f5e"},{"key":"e_1_2_6_47_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2003.01.063"},{"key":"e_1_2_6_48_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.soc.2005.12.012"},{"key":"e_1_2_6_49_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.sla.0000086543.45557.cb"},{"key":"e_1_2_6_50_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1999.17.10.3238"},{"key":"e_1_2_6_51_2","doi-asserted-by":"publisher","DOI":"10.1097\/SLA.0b013e3181fca894"},{"key":"e_1_2_6_52_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2006.09.4573"},{"key":"e_1_2_6_53_2","doi-asserted-by":"publisher","DOI":"10.1038\/ncponc0041"},{"key":"e_1_2_6_54_2","first-page":"2253","article-title":"Molecular markers in blood as surrogate prognostic indicators of melanoma recurrence","volume":"60","author":"Hoon DS","year":"2000","journal-title":"Cancer Res"},{"key":"e_1_2_6_55_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-0823"},{"key":"e_1_2_6_56_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.04.098"},{"key":"e_1_2_6_57_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1995.13.8.2109"},{"key":"e_1_2_6_58_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2006.081828"},{"key":"e_1_2_6_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-0215(19970703)72:1<191::AID-IJC27>3.0.CO;2-L"},{"key":"e_1_2_6_60_2","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2008.116467"},{"key":"e_1_2_6_61_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp280"},{"key":"e_1_2_6_62_2","doi-asserted-by":"crossref","first-page":"Abstract 9045","DOI":"10.1200\/jco.2009.27.15_suppl.9045","article-title":"Validation of a multimarker blood assay for postoperative assessment of stage IV melanoma patients in a prospective international phase III trial","volume":"27","author":"Hoshimoto S","year":"2009","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_63_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2009.03.011"},{"key":"e_1_2_6_64_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.293.5532.1103"},{"key":"e_1_2_6_65_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-1169-3"},{"key":"e_1_2_6_66_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1002011"},{"key":"e_1_2_6_67_2","doi-asserted-by":"crossref","first-page":"Abstr 8503","DOI":"10.1200\/jco.2010.28.15_suppl.8503","article-title":"Phase I\/II study of GSK2118436, a selective inhibitor of oncogenic mutant BRAF kinase, in patients with metastatic melanoma and other solid tumors","volume":"28","author":"Kefford R","year":"2010","journal-title":"J Clin Oncol"},{"key":"e_1_2_6_68_2","first-page":"1087","article-title":"cDNA cloning of mouse ret proto\u2010oncogene and its sequence similarity to the cadherin superfamily","volume":"8","author":"Iwamoto T","year":"1993","journal-title":"Oncogene"},{"key":"e_1_2_6_69_2","first-page":"571","article-title":"Cloning and expression of the ret proto\u2010oncogene encoding a tyrosine kinase with two potential transmembrane domains","volume":"3","author":"Takahashi M","year":"1988","journal-title":"Oncogene"},{"key":"e_1_2_6_70_2","doi-asserted-by":"publisher","DOI":"10.1038\/nrc2037"},{"key":"e_1_2_6_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1359-6101(01)00012-0"},{"key":"e_1_2_6_72_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1349-7006.2005.00023.x"},{"key":"e_1_2_6_73_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-2742"},{"key":"e_1_2_6_74_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-05-2843"},{"key":"e_1_2_6_75_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.164"},{"key":"e_1_2_6_76_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1200203"},{"key":"e_1_2_6_77_2","first-page":"7422","article-title":"Loss of expression of the metastasis suppressor gene KiSS1 during melanoma progression and its association with LOH of chromosome 6q16.3\u2010q23","volume":"61","author":"Shirasaki F","year":"2001","journal-title":"Cancer Res"},{"key":"e_1_2_6_78_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-03-2932"},{"key":"e_1_2_6_79_2","doi-asserted-by":"publisher","DOI":"10.1002\/jcp.21224"},{"key":"e_1_2_6_80_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-1361"},{"key":"e_1_2_6_81_2","doi-asserted-by":"publisher","DOI":"10.4161\/epi.6.3.14056"},{"key":"e_1_2_6_82_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.med.59.061606.095816"},{"key":"e_1_2_6_83_2","doi-asserted-by":"publisher","DOI":"10.1177\/107327480901600302"},{"key":"e_1_2_6_84_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207505"},{"key":"e_1_2_6_85_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.14.0723"},{"key":"e_1_2_6_86_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-08-3172"},{"key":"e_1_2_6_87_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.onc.1207755"},{"key":"e_1_2_6_88_2","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2010.88"},{"key":"e_1_2_6_89_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0996-1033"},{"key":"e_1_2_6_90_2","doi-asserted-by":"publisher","DOI":"10.1038\/nm0996-1035"},{"key":"e_1_2_6_91_2","first-page":"1527","article-title":"Detection of K\u2010ras gene mutations in plasma DNA of patients with pancreatic adenocarcinoma: Correlation with clinicopathological features","volume":"4","author":"Yamada T","year":"1998","journal-title":"Clin Cancer Res"},{"key":"e_1_2_6_92_2","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djh011"},{"key":"e_1_2_6_93_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-04-0957"},{"key":"e_1_2_6_94_2","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-06-2120"},{"key":"e_1_2_6_95_2","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-06-0801"},{"key":"e_1_2_6_96_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2005.02.9876"}],"container-title":["Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fjso.21969","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/jso.21969","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T02:20:02Z","timestamp":1694398802000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/jso.21969"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,5,9]]},"references-count":95,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,9,15]]}},"alternative-id":["10.1002\/jso.21969"],"URL":"https:\/\/doi.org\/10.1002\/jso.21969","archive":["Portico"],"relation":{},"ISSN":["0022-4790","1096-9098"],"issn-type":[{"value":"0022-4790","type":"print"},{"value":"1096-9098","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,5,9]]}}}